287 results
Page 9 of 15
8-K
EX-99.1
u7rfcd
13 Mar 20
VBI Vaccines Appoints Damian Braga to Board of Directors
12:59pm
8-K
EX-99.1
px5v0
5 Mar 20
VBI Vaccines Provides Corporate Update, Outlook for 2020, and Year-End 2019 Financial Results
12:40pm
8-K
EX-99.1
4qsbcs
3 Mar 20
Other Events
10:00am
8-K
EX-99.1
a9fh5la4kxj xb1jl
2 Mar 20
Other Events
11:14am
8-K
EX-99.1
4lfniiqqen80wcp7p
15 Jan 20
Other Events
6:05am
8-K
EX-99.1
e82o8o21bp6bk0oo1uli
10 Jan 20
VBI Vaccines Announces Second Pivotal Phase 3 Study of Sci-B-Vac® Meets Primary and Secondary Endpoints
3:23pm
8-K
EX-99.1
hpyv83kt34za4v
22 Nov 19
Other Events
8:11am
8-K
EX-99.1
g41mcnd wmjn4n9olvf4
14 Nov 19
Other Events
4:54pm
8-K
EX-99.1
303sb6 7gzbzg
12 Nov 19
VBI Vaccines to Present Initial Phase 1/2a Part B Data of VBI-1901 at the 2019 Society for Neuro-Oncology (SNO) Annual Meeting
6:15am
8-K
EX-99.1
q8njh5hccg8mvu1t
6 Nov 19
VBI Vaccines Announces Third Quarter 2019 Financial Results and Provides Corporate Update
8:51am
8-K
EX-99.1
24lv4u9ms1vij4g9iwp
25 Oct 19
VBI Vaccines to Present New Immuno-Oncology Data at the World Vaccine Congress Europe 2019
12:00am
8-K
EX-99.1
8ac f62w39
23 Oct 19
VBI Vaccines Announces Late-Breaker Poster Presentation at The Liver Meeting® 2019
6:05am
8-K
EX-99.1
mn70ubyzw1wx3 2a
2 Oct 19
Other Events
9:00am
8-K
EX-99.1
d6qijcafh
26 Sep 19
VBI Vaccines Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
8:05am
424B5
3sf22w4l9nbp p9u
20 Sep 19
Prospectus supplement for primary offering
5:28pm
8-K
EX-99.1
0mi5pszzze82v
20 Sep 19
VBI Vaccines Announces Proposed Public Offering of Common Shares
5:27pm
8-K
EX-1.1
tdd9gjdn89jiv
20 Sep 19
VBI Vaccines Announces Proposed Public Offering of Common Shares
5:27pm
8-K
EX-99.2
a4ha7zl4g4rv xxf2dz
20 Sep 19
VBI Vaccines Announces Proposed Public Offering of Common Shares
5:27pm